Cite

MLA Citation

    M R Mirza et al.. “Latest clinical evidence and further development of PARP inhibitors in ovarian cancer.” Annals of oncology, vol. 29, 2018, pp. 1366–1376. http://access.bl.uk/ark:/81055/vdc_100095506622.0x00003a
  
Back to record